Evaluation of a Compound Modling Method with N-methyl-N’-nitro-N-nitrosoguanidine for Establishing Chronic Atrophic Gastritis Model Rats

REN Jingang; YANG Yang; QU Xianhou; YIN Lu; YANG Min; YAN Ningjuan; LIU Tao; WEI Wei

doi:10.13288/j.11-2166/r.2017.22.016

您当前的位置：

首页 >

文章列表页 >

Evaluation of a Compound Modling Method with N-methyl-N’-nitro-N-nitrosoguanidine for Establishing Chronic Atrophic Gastritis Model Rats

更新时间：2021-11-10

- Evaluation of a Compound Modling Method with N-methyl-N’-nitro-N-nitrosoguanidine for Establishing Chronic Atrophic Gastritis Model Rats
- Journal of Traditional Chinese Medicine Vol. 58, Issue 22, Pages: 1961-1964(2017)
- 作者机构：
  
  1. 首都医科大学附属北京中医医院
  2. 中国中医科学院望京医院
  3. 北京中医药大学
- 作者简介：
- 基金信息：
- DOI：10.13288/j.11-2166/r.2017.22.016
  CLC： R573.32;R-332
- Published：2017
- 稿件说明：
移动端阅览
[1]任金刚,杨洋,瞿先侯,尹璐,杨敏,严宁娟,刘涛,魏玮.慢性萎缩性胃炎大鼠N-甲基-N'-硝基-N-亚硝基胍复合造模法模型评价[J].中医杂志,2017,58(22):1961-1964.

REN Jingang, YANG Yang, QU Xianhou, et al. Evaluation of a Compound Modling Method with N-methyl-N’-nitro-N-nitrosoguanidine for Establishing Chronic Atrophic Gastritis Model Rats[J]. Journal of Traditional Chinese Medicine2017, 58(22): 1961-1964.
[1]任金刚,杨洋,瞿先侯,尹璐,杨敏,严宁娟,刘涛,魏玮.慢性萎缩性胃炎大鼠N-甲基-N'-硝基-N-亚硝基胍复合造模法模型评价[J].中医杂志,2017,58(22):1961-1964. DOI： 10.13288/j.11-2166/r.2017.22.016.

REN Jingang, YANG Yang, QU Xianhou, et al. Evaluation of a Compound Modling Method with N-methyl-N’-nitro-N-nitrosoguanidine for Establishing Chronic Atrophic Gastritis Model Rats[J]. Journal of Traditional Chinese Medicine2017, 58(22): 1961-1964. DOI： 10.13288/j.11-2166/r.2017.22.016.

摘要

目的评价慢性萎缩性胃炎N-甲基-N’-硝基-N-亚硝基胍（MNNG）复合造模法的稳定性及对动物肝脏的影响。方法 60只SPF级健康雄性SD大鼠随机分为正常组8只及造模1组、造模2组各26只。造模1组用MNNG复合高盐热淀粉糊法、造模2组采用MNNG复合乙醇灌胃法制备慢性萎缩性胃炎大鼠模型

正常组正常饲养。造模时间28周。造模后比较造模1组、造模2组大鼠胃黏膜病理程度

血清胃蛋白酶原Ⅰ（PGⅠ）、胃蛋白酶原Ⅱ（PGⅡ）及肝脏病理改变。结果造模1组大鼠24周出现腺体异型增生

26周出现灶性肠化生。造模2组大鼠26周出现个别腺体异型增生

28周出现灶性肠化生。模型1组死亡率为26.9%

模型2组为15.4%。造模后造模1组、造模2组大鼠胃黏膜病理改变差异无统计学意义（P>0.05）。与正常组比较

造模1组、造模2组血清PGⅠ、PGⅠ/PGⅡ降低（P<0.05）。28周造模1组及造模2组大鼠肝脏细胞均出现水样变性。结论慢性萎缩性胃炎MNNG复合造模法造模时间较长

模型死亡率较高

并且对大鼠肝脏组织有一定影响。

Abstract

Objective To evaluate the stability of a compound modeling method of chronic atrophic gastritis with N-methyl-N’-nitro-N-nitrosoguanidine（ MNNG） and its effect on animal hepatocytes. Methods Sixty specificpathogen-free healthy male Sprague Dawley rats were randomly divided into a normal group（ n = 8）

a model group 1（ n = 26） and a model 2 group（ n = 26）. The model group 1 adopted MNNG combined with high salt hot starch paste method and the model 2 group adopted MNNG combined with ethanol gavage method to prepare rat model with chronic atrophic gastritis. The normal group received normal feeding. Rats underwent modeling for twenty eight weeks. Gastric mucosa pathological degree

serum levels of pepsinogen Ⅰ（ PG Ⅰ） and pepsinogen Ⅱ（ PG Ⅱ）

and the change of liver pathology of rats in the model group 1 and the model 2 group were compared after modeling. Results Rats in the model group 1 had gland hyperplasia at the 24 week

and had focal intestinal metaplasia at the 26 week.Rats in the model 2 group had individual gland hyperplasia at the 26 week

and had focal intestinal metaplasia at the28 week.

The mortality rate was 26. 9% in the model 1 group

and 15. 4% in the model 2 group. After modeling

there was no statistically significant difference in gastric mucosa pathological changes between rats in the model 1 and in the model 2 group（ P > 0. 05）. Compared with those in the normal group

serum levels of PGⅠ

and PGⅠ/PGⅡ in the model 1 group and model group 2 decreased（ P < 0. 05）. At the 28 week of modeling

hepatocytes of both rats in the model 1 group and model group 2 appeared hydropic degeneration. Conclusion The MNNG compound modeling method of establishing model of chronic atrophic gastritis needs longer modeling time. It is with high mortality

and has a certain effect on the liver tissue of rats.

关键词

Keywords

references

查看原文

Views

296

下载量

CSCD

Alert me when the article has been cited

提交

Tools

Publicity Resources

A Randomized Controlled Trial of Jianpi Jiedu Formulation （健脾解毒方） in the Treatment of Kimura-Takemoto Closed-Type Atrophic Gastritis with Spleen Deficiency and Damp-Heat Syndrome

SHAN Zhaowei's Experience in Treating Chronic Atrophic Gastritis with the Three-Unblocking Method

Prevention and Treatment of Inflammation-Cancer Transformation in Chronic Atrophic Gastritis Based on Collateral Disease Theory

Clinical Study on the Treatment of 70 Cases Chronic Atrophic Gastritis with Intestinal Metaplasia Using Xianglian Huazhuo Granules （香连化浊颗粒）：A Randomized，Double-Blind，Placebo-Controlled Trial

Construction of a Disease-Syndrome Integrated Diagnosis and Treatment System for Gastric "Inflammation-Cancer" Transformation Based on Multi-Modal Phenotypic Modeling

Related Author

GU Bingyan

QIN Danping

YANG Xinyan

ZHANG Yusen

PENG Liqing

ZHANG Ke

GU Peiqing

单兆伟

Related Institution

Huzhou Central Hospital

Zhejiang Provincial Hospital of Traditional Chinese Medicine

The First Clinical Medical College，Zhejiang Chinese Medical University

南京中医药大学附属医院，江苏省南京市秦淮区汉中路155号

Affiliated Hospital of Nanjing University of Traditional Chinese Medicine

Address：No.16, Nanxiao street, Dongzhimen, Dongcheng District, Beijing Postal code：100700
Tel：010-64035632 Email：jtcmcn@188.com
Technical support is provided by Beijing Founder electronics co., LTD 京ICP备09064830号-19 京公网安备11010102007558号
It is recommended to read the content of this site in Chrome&IE9+. Please switch to extreme mode in browser 360.
Cookies We use cookies to help provide and enhance our service and tailor content. By continuing, you agree to the use of cookies.

⁰